Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies

Details for Australian Patent Application No. 2008259939 (hide)

Owner OMT, Inc.

Inventors Buelow, Ronald

Agent Davies Collison Cave

Pub. Number AU-A-2008259939

PCT Pub. Number WO2008/151081

Priority 60/914,619 01.06.07 US; 61/044,324 11.04.08 US

Filing date 30 May 2008

Wipo publication date 11 December 2008

International Classifications

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/151081 Priority application(s): WO2008/151081

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008259946-Immunoglobulin constant region Fc receptor binding agents

2008259937-Compositions for degrading cellulosic material